InsidersTradesSigma
Discover the detailed record of transactions filed by Madden Martin J., Director. Officer active across 1 company, notably NovoCure Ltd. In total, 4 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €9k. Activity tracked since 9 June 2021. The latest transaction was disclosed on 5 August 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
Martin J. Madden is a Board Member at NovoCure Ltd. He has a strong background in corporate governance and strategic development. Martin contributes to guiding board decisions and implementing best practices within the company.